Serial Number
79256120
Owner
Vernx Biotechnology Pty LtdAttorney
Michelle P. CiotolaFiling Date
Feb 26, 2019
NUTRITION ADVANCING LIFE Trademark
Serial Number: 79256120 • Registration: 5969827
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Michelle P. Ciotola Cantor Colburn LLP
20 Church St.
22nd Floor
Hartford, CT 06103
UNITED STATES
Trademark Details
Filing Date
February 26, 2019
Registration Date
January 28, 2020
Published for Opposition
November 12, 2019
Cancellation Date
August 14, 2026
Goods & Services
Scientific and technological services and research and design relating thereto, namely pharmaceutical research and new product development, research and design thereto; scientific and technological research services in the pharmaceutical, biotechnology, biochemistry and chemistry fields; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry research and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the efficacy and safety of pharmaceuticals, namely pharmaceutical product evaluation and testing and inspection of pharmaceuticals; preparation of scientific reports relating to scientific research; analytical laboratory services, namely chemical and medical laboratories; laboratory research and analysis in the pharmaceutical, biotechnology, biochemistry and chemistry fields; development of products; development of new products; advisory services relating to scientific research; scientific consultancy and information services relating to the aforementioned services
Pharmaceutical preparations and substances for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; gastro-intestinal treatment preparations; medicines for human use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; medicines for intestinal disorders; pharmaceutical products, namely pills, capsules, tablets, caplets, liquid drops, sachets and beverages for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemical preparations for pharmaceutical purposes for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemicals for pharmaceutical use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; diagnostic preparations for medical purposes; pharmaceutical preparations, herbal supplements and veterinary preparations all for the prevention, treatment and management of immune disorders and inflammatory diseases of the gastrointestinal system